IP Library Granted Patent US 11,273,260
Granted Patent B2
US 11,273,260 · App. 17/350,883 · Granted Mar 15, 2022

Injector and method of assembly

Inventors: Francisca Tan-Malecki (Westlake Village, CA); Ronald Forster (Simi Valley, CA); Scott M. Nunn (San Mateo, CA); Mark D. Holt (Moorpark, CA); Son C. Tran (San Francisco, CA); Sheldon Moberg (Thousand Oaks, CA)
Assignee: AMGEN INC.
A61M5/31A61M5/148A61M5/1452A61M5/158A61M5/162A61M5/1626A61M5/172A61M5/2466B65B3/003B65B7/2821B65B55/08B65B55/10A61M5/14244A61M5/2455A61M2005/247A61M2005/2474A61M2005/3114A61M2207/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,273,260
App. No.
17/350,883
Granted
Mar 15, 2022
Kind
B2
Abstract

An injector may include a container having a wall with an interior surface and a seal assembly with an interior surface, the interior surfaces of the wall and the seal assembly defining a closed sterile reservoir filled with a drug product. The injector may also include a fluid delivery system comprising a clean, unsheathed, rigid container needle having a point disposed only partially through the seal assembly in a storage state, and disposed through the interior surface of the seal assembly into the sterile reservoir in a delivery state. Further, the injection may include an actuator that is adapted to move the container needle from the storage state to the delivery state.

Claims (22)

1. An injector comprising:

a container including a wall with an interior surface and a septum with an interior surface, the interior surfaces of the wall and the septum at least partially defining a reservoir, wherein the septum is fixed relative to the wall of the container;

a stopper positioned within the container;

a fluid delivery system comprising a container needle having a point, the container needle having a storage state and a delivery state; and

a clean barrier positioned exterior to the septum such that the septum and the clean barrier at least partially define an enclosed space disposed between the septum and the clean barrier, the point of the container needle being disposed adjacent to the clean barrier in the storage state and disposed through the septum in the delivery state,

wherein the container needle and the clean barrier are configured such that the container needle moves independently of the clean barrier in moving from the storage state to the delivery state.

2. The injector of claim 1 , wherein the clean barrier is free from contact with the septum.

3. The injector of claim 1 , wherein the clean barrier is immovable relative to the wall of the container.

4. The injector of claim 1 , wherein the clean barrier is coupled with the container needle such that the point of the container needle penetrates the clean barrier in the storage state.

5. The injector of claim 1 , comprising an actuator configured to move the container needle from the storage state to the delivery state.

6. The injector of claim 5 , comprising a mechanical input device coupled to the actuator.

7. The injector of claim 5 , comprising an electrical or electro-mechanical input device coupled to the actuator.

8. The injector of claim 1 , wherein the septum comprises a flexible unitary wall.

9. The injector of claim 1 , comprising:

an injection needle for insertion into a patient; and

a flexible tubing connecting the container needle and the injection needle.

10. The injector of claim 1 , wherein the clean barrier comprises a second septum and the container needle is disposed through the second septum in the delivery state.

11. The injector of claim 1 , wherein the injector is manufactured with the point of the container needle disposed in the enclosed space in the storage state.

12. The injector of claim 1 , wherein the point of the container needle is disposed in the enclosed space prior to any user-initiated movement of the container needle relative to the container.

13. The injector of claim 1 , wherein the injector is packaged with the point of the container needle disposed in the enclosed space in the storage state.

14. The injector of claim 1 , wherein the point of the container needle is initially, prior to use, disposed stationarily in the enclosed space in the storage state.

15. The injector of claim 1 , comprising a drug disposed in the container, the drug comprising at least one of: a granulocyte colony-stimulating factor, a pegylated granulocyte colony-stimulating factor, a PCSK9-specific antibody, an erythropoiesis stimulating agent, a TNF blocker, an interleukin-receptor specific antibody, an IGF-receptor specific antibody, or a TGF-specific antibody.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 18, 2021
From: TAN-MALECKI, FRANCISCA; FORSTER, RONALD; NUNN, SCOTT M.; HOLT, MARK D.; TRAN, SON C.; MOBERG, SHELDON
To: AMGEN INC.
Reel/Frame 056627/0597 →
Continuity (5)
Continuation 16687254 · Nov 18, 2019
Continuation 15040308 · Feb 10, 2016
Continuation 14350687
Provisional Application 61547667 · Oct 14, 2011
Related Publication 20210308381A1 · Oct 7, 2021
Cited By (4)
US 1,122,440 US 12,226,613 US 12,533,298 US 12,691,213